World Tumor Registry Partners with PathPresenter to Launch a World-Wide Educational Platform to Improve Cancer Diagnosis

September 17, 2024 – The World Tumor Registry (“WTR”), a comprehensive, searchable, open-access catalog of digital microscopic images of human cancer types and subtypes, has partnered with PathPresenter, a secure and scalable multi-tenant enterprise pathology workflow software platform, to provide a powerful education resource for individuals and public organizations around the world involved in cancer care and research.

The World Tumor Registry was founded in 2021 by Dr. Yuri Nikiforov, Professor of Pathology at the University of Pittsburgh School of Medicine. The WTR’s cloud-based registry was developed to minimize diagnostic errors, eliminate inequality in cancer recognition, diagnosis, and treatment in diverse populations, and improve patient outcomes. Through an intuitive user interface, pathologists and other medical professionals can learn, review, and explore the diagnostic microscopic features of tumors, accompanied by clinical, immunohistochemical, and molecular information that have been contributed from every region of the world and annotated by experts. Further, scientists can study cancer microscopic features across diverse geographic regions and demographic groups. Patients and other individuals can enhance their knowledge of cancer through microscopic visualization. The registry of thyroid cancer was launched by WTR in March of this year, and the registries of breast cancer and lung cancer are the next two organ sites to go live next year. 

PathPresenter plays a key role in the collaboration by providing sophisticated image management and image viewing software for the tumor registry. Using PathPresenter’s industry-leading image rendering engine, WTR users can quickly and easily navigate the high-resolution whole slide images and associated case information, which have been expertly annotated with relevant demographic and clinical information.  

“We are thrilled to partner with PathPresenter to develop and offer this unique educational resource for the users around the world,” said Dr. Yuri Nikiforov, Founder and President of WTR.

“Working with Dr. Nikiforov has been an incredible experience as the mission and vision of both pathologists-led organizations – PathPresenter and WTR – is to democratize accessibility to pathology knowledge and expertise so that patients can get a better and faster diagnosis,” adds Dr. Rajendra Singh, founder of PathPresenter. “The complexity of pathology is based on the myriad histological variants of every type of cancer and WTR provides a searchable resource for finding all histological variants in a single place.” 

About the World Tumor Registry

The World Tumor Registry (WTR) is a non-profit 501(c)(3) organization focused on establishing a comprehensive, searchable, open-access catalog of digital microscopic images of human cancer types and subtypes occurring in different geographic regions, populations, and environmental settings. It serves as a unique educational and practical resource for individuals and public organizations involved in cancer care and research. Learn more about the World Tumor Registry https://www.worldtumorregistry.org.

About PathPresenterPathPresenter is the global image sharing platform for pathology. We are on a mission to democratize access to the world’s pathology knowledge by connecting pathologists to the vast expertise of their colleagues globally and providing a practical platform to access and use best-in-class AI models. Founded by dermatopathologist and digital pathology pioneer, Dr. Rajendra Singh, PathPresenter’s secure and scalable multi-tenant enterprise pathology workflow software has been adopted by 45+ tier one medical institutions for clinical care, education, and research, and the company has built a thriving community of 50,000+ users in 172 countries to easily view and share digital pathology images and knowledge. Learn more at https://pathpresenter.stg1.parel.co.

PathPresenter Raises $7.5 Million to Accelerate Adoption of Digital Pathology Workflows

AVANT BIO, Barco NV and Modi Ventures Back Pathologist-Built Platform 

PathPresenter, the global image sharing platform for pathology, announced today that it has closed a Series A funding round of $7.5 million to accelerate the adoption of the company’s enterprise pathology workflow solution. The funding was led by AVANT BIO, with participation from Barco NV and Modi Ventures. The funds will be used to advance the features and interoperability of the vendor-agnostic platform, invest in talent across engineering and commercial functions, and accelerate the achievement of regulatory milestones.

Founded by dermatopathologist and digital pathology pioneer Dr. Rajendra Singh, PathPresenter began as a free online platform for pathology education and rapidly became the world’s largest and fastest-growing digital pathology community with more than 50,000 users in 172 countries. Responding to the needs of institutions, the company began building a secure and scalable enterprise platform and extended the pathology use cases to include clinical care, remote consultations and research, partnering with visionary third-party vendors to create the most comprehensive and interoperable pathology workflow solution available. 

Today, PathPresenter’s vendor-agnostic enterprise platform empowers more than 50 top-tier hospitals, labs and pharma companies to create seamless and powerful digital pathology workflows that connect their institution and pathologists to the vast expertise of their colleagues around the world. The platform leverages promising new artificial intelligence (AI) algorithms and foundational models to enhance patient outcomes and create new profit centers from digital pathology investments. 

Industry and Executive Insights

• Imogen Fitt, Senior Market Analyst, Signify Research
  “The ability to select multiple vendor products and exchange information between them, known as interoperability, is crucial in today’s digital pathology landscape as customers increasingly want the freedom to select multiple ‘best-of-breed’ scanners, workflow software and AI solutions. By establishing a standards-based, open environment that offers labs choice and ensures tight integration, vendors will help overcome one of the leading barriers to user adoption, while also entrenching deeper into customer workflows. This approach will drive the next phase of digital pathology.”
• Sebastien Latapie, Principal, AVANT BIO
  “PathPresenter’s unique, pathologist-built platform immediately impressed us with its strong adoption among pathologists, demonstrating clear value in solving digital pathology workflows’ unmet needs. At AVANT BIO, we back current technologies that are capable of driving life sciences and healthcare forward. PathPresenter’s vision to unlock digital pathology’s potential through improved connectivity and accessibility aligns with AVANT BIO’s mission. We’re excited to support this world-class team in democratizing today’s pathology expertise globally.” 
• Dr. Rajendra Singh, Founder, PathPresenter
  “PathPresenter has consistently aimed to close the gaps in the use of digital pathology across clinical care, education and research. We’ve been fortunate to partner with visionaries who have helped make PathPresenter the nation’s fastest growing digital pathology platform. Our recent funding round has brought in more outstanding partners who share our vision, and their support will be key in expanding PathPresenter’s reach, positioning it as the leading digital pathology platform worldwide.”
• Patrick Myles, CEO, PathPresenter
  “Over the next five years, many of the world’s 1 billion glass biopsy slides produced annually will be digitized, creating a generational opportunity to democratize access to the world’s pathology knowledge. PathPresenter is building the much-needed ‘roads and bridges’ that will enable institutions and pathologists to more easily share image data, AI tools and domain expertise. This investment reaffirms the potential of our platform and team, and the critical role that vendor-agnostic workflow plays in pathology’s digital future.”

About PathPresenter
PathPresenter is the global image sharing platform for pathology. We are on a mission to help democratize access to the world’s pathology knowledge by connecting pathologists to the vast expertise of their colleagues globally and providing a practical platform to access and use best-in-class AI models. The company was founded by dermatopathologist and digital pathology pioneer Dr. Rajendra Singh. PathPresenter’s enterprise platform has been adopted by tier one medical institutions for clinical care, education and research. Through its free pathology education platform, PathPresenter has built the world’s largest digital pathology community with more than 50,000 users in 172 countries. For more information on PathPresenter visit www.pathpresenter.com.

Media Contact
Maria Bradley
R2PR for PathPresenter
maria@bradley.name
415-509-0498 mobile/office

Blind Review and PathPresenter Partner to Eliminate Expert Witness Bias in Pathology Malpractice Cases

Cincinnati and Montville, NJ | March 11, 2024 01:00 PM Eastern Daylight Time

Blind Review, LLC, the secure digital platform for eliminating expert witness bias, and PathPresenter, the global image sharing platform for pathology, today announced a strategic partnership ushering digital pathology into the medical malpractice space. This alliance will revolutionize how pathology expert reviews are conducted in malpractice cases, transforming it from the old-school, glass-slide model to a cutting-edge, digital model that increases efficiency, streamlines access, and simplifies the traditional pathology review.

Blind Review specializes in removing hindsight, financial, and party-identity bias from expert witnesses through a proprietary digital platform and customized process. Once onboarded to the platform, experts are digitally placed into the shoes of the treating physician. As the care-story unfolds, the expert’s opinion is captured at each critical point of care, all while shielding the identity of the attorney, client, and care outcome. Importantly, the process prevents the expert from knowing what comes next without first committing to an opinion based only on the records available at that point in the care – eliminating hindsight bias.

PathPresenter is a secure and scalable multi-tenant enterprise pathology workflow platform that has been developed by pathologists with deep domain knowledge and experience. Trusted by over 45 tier-one medical institutions, PathPresenter is the most comprehensive image management/viewing suite available for clinical care, remote consultations, education, and research.

Pathologists play a critical role in reviewing medical malpractice cases for disease diagnosis or when timing of an injury or cause of death is in question. PathPresenter has taken the desktop microscope and transformed it into a state-of-the-art digital viewer that pathologists can access anytime, anywhere to review microscopic evidence in a legal case. Utilizing PathPresenter’s cloud-based, clinical consultation platform, Blind Review’s proprietary process is far more efficient and eliminates the risks and limitations that come with glass slides.

“Juror’s trust in experts has fallen to levels below where they were before the pandemic, and we continue to see very large, unexpected verdicts,” says Blind Review’s CEO and attorney-founder, Stephanie Franckewitz. “Independent research supports that a blinded expert doubles the chances of a favorable verdict because jurors perceive them as significantly more credible. We are proud to partner with PathPresenter, and we are in good company, as many of the world’s elite medical institutions use PathPresenter on a day-to-day basis in their pathology departments.”

“PathPresenter’s partnership with Blind Review brings the practice of expert pathology review within the medical malpractice space into the 21st century,” adds Patrick Myles CEO of PathPresenter. “Whether in the courtroom or in the pathology lab, expert opinion is all about trust. By partnering with Blind Review, we’re enabling a never-before-seen way to restore jurors’ trust in experts.”

About Blind Review, LLC
Blind Review is the digital platform that provides the infrastructure to eliminate expert witness bias in medical malpractice cases. We deliver a strong competitive advantage to the trial teams who share our vision: Unbiased, reliable, and trustworthy expert opinions. Blind Review digitally places the expert into the shoes of the treating healthcare provider. As the care-story unfolds, the expert’s opinion is captured at each critical point of care, all while shielding the identity of the attorney, client, and care outcome. Simple and intuitive, our cloud-based interface allows robust customization, with the ability to deliver our unique Blind Review process across multiple specialties within a single case. Blind Review’s platform includes seamless integration with a secure cloud-based Radiology PACS system and Digital Pathology system, with state-of-the-art viewers.

About PathPresenter
PathPresenter is the global image sharing platform for pathology. We are on a mission to help democratize access to the world’s pathology knowledge by connecting pathologists to the vast expertise of their colleagues globally and providing a practical platform to access and use best-in-class AI models. Founded by dermatopathologist and digital pathology pioneer, Dr. Rajendra Singh, PathPresenter has been adopted by 45+ tier one medical institutions for clinical care, education, and research, and has built a thriving community of 50,000+ users in 172 countries to easily view and share digital pathology images and knowledge.

###

Media Inquiries:

Michelle Rupp 501-658-9277 or michelle@memorableresultsmedia.com

Ibex and PathPresenter Launch Partnership to Accelerate Adoption of AI-powered Digital Pathology

BOSTON and MONTVILLE, N.J., March 6, 2024 /PRNewswire/ — Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, and PathPresenter, the global image sharing platform for pathology, today announced a partnership to advance the adoption of AI-powered digital pathology. The two companies will work together to support joint customers via an AI-powered digital pathology solution for laboratories, hospitals and health systems worldwide.

“The digital pathology and AI transformation that Ibex and PathPresenter are championing is modernizing the industry and providing pathologists with AI tools to improve diagnostic accuracy, lab efficiencies and patient outcomes,” said Joseph Mossel, CEO and Co-Founder of Ibex Medical Analytics. “This partnership allows us to expand access to Galen™, Ibex’s AI platform, to PathPresenter’s impressive community of medical institutions around the world.”

PathPresenter is a secure and scalable multi-tenant enterprise workflow platform that has been developed by pathologists with deep domain knowledge and experience. Trusted by over 45 tier-one institutions, PathPresenter is the most comprehensive suite available for clinical care, remote consultations, education, and research. The solution provides expert guidance in storage optimization, tight integration with LIS systems through a proprietary HL7 engine, and robust incorporation of 3rd party and in-house-built AI algorithms.

“We are committed to working with the best partners to advance digital pathology adoption and education, and Ibex is a clear leader in AI-powered diagnostics,” said Dr. Rajendra Singh, founder of PathPresenter. “PathPresenter is building the much-needed ‘roads and bridges’ to connect the world’s pathologists, institutions, and pharma companies to easily share image data, AI algorithms, and domain expertise. Our deep knowledge of the digital pathology workflows is complemented well by Ibex’s clinically validated AI tools, enabling pathologists to benefit from a holistic diagnostic experience.”

Ibex’s Galen platform is the most widely deployed AI technology in pathology and has been deployed in laboratories and pathology departments around the world. Galen supports clinicians worldwide with augmented capabilities during diagnosis of breast, prostate, and gastric biopsies. Improving diagnostic accuracy, reducing turnaround time, optimizing lab workflows and improving user experience for pathologists, Galen has demonstrated excellent outcomes across multiple clinical studies performed in different pathology labs and diagnostic workflows.^1,2,3,4,5

Ibex and PathPresenter will be at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting in Baltimore, between March 23 and 28, 2024 (Ibex booth no. 755, PathPresenter booth no. 953).

About Ibex Medical Analytics
Ibex Medical Analytics is transforming cancer diagnostics with clinical grade AI-powered solutions for pathology. Empowering clinicians and supporting pathologists, Ibex is on a mission to provide accurate, timely and personalized cancer diagnosis for every patient. Ibex’s Galen™ is the first and most widely deployed AI-powered platform in pathology. Pathologists worldwide use Galen™ as part of their everyday routine to improve the accuracy of cancer diagnosis, implement comprehensive quality control measures, reduce turnaround times and optimize workflows. For additional company information, please visit https://ibex-ai.com/ and follow us on LinkedIn and X.

Multiple solutions under the Galen™ platform are CE marked (IVDD) and registered with the UK MHRA. Galen First Read for prostate is now also CE marked under IVDR. The Galen platform includes solutions which are for Research Use Only (RUO) in the United States and not cleared by the FDA. For more information, including indication for use and regulatory approval in other countries, contact Ibex Medical Analytics.

About PathPresenter
PathPresenter is the global image sharing platform for pathology. We are on a mission to help democratize access to the world’s pathology knowledge by connecting pathologists to the vast expertise of their colleagues globally and providing a practical platform to access and use best-in-class AI models. Founded by dermatopathologist and digital pathology pioneer, Dr. Rajendra Singh, PathPresenter has been adopted by 45+ tier one medical institutions for clinical care, education, and research, and has built a thriving community of 50,000+ users in 172 countries to easily view and share digital pathology images and knowledge.

Ibex Media Contact
Nechama Rosengarten
FINN Partners
Nechama.rosengarten@finnpartners.com 

PathPresenter Media Contact
Cory Batenchuk
SVP of Operations
cory@pathpresenter.com

[1] Sandbank et al., Validation and real-world clinical application of an artificial intelligence algorithm for breast cancer detection in biopsies, npj Breast Cancer, December 2022 

[2] Pantanowitz et al., An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study, THE LANCET Digital Health Aug 2020

[3] Comperat et al., Clinical Level AI-Based Solution for Primary Diagnosis and Reporting of Prostate Biopsies in Routine Use: A Prospective Reader Study, European Congress of Pathology 2021

[4] Raoux et al., Novel AI-Based Solution for Supporting Primary Diagnosis of Prostate Cancer Increases the Accuracy and Efficiency of Reporting in Clinical Routine, USCAP 2021

[5] Sandbank et al., Validation and Clinical Deployment of an AI-Based Solution for Detection of Gastric Adenocarcinoma and Helicobacter pylori in Gastric Biopsies, USCAP 2022

SOURCE Ibex Medical Analytics; PathPresenter

PathPresenter Surpasses 50,000 Global Users

Montville, NJ – PathPresenter, the global image sharing platform for pathology, today announced that their free public platform (https://pathpresenter.net/) now has more than 50,000 registered users in 172 countries. Nearly 7,000 users have joined the pathology image sharing community in the past 12 months.

Founded by dermatopathologist and digital pathology innovator, Dr. Rajendra Singh, PathPresenter has become the go-to, on-line community for pathologists, residents, fellows, scientists, and researchers who want to easily upload, view, and share whole slide images with their colleagues, as well as access curated image datasets from trusted experts. With over 100,000 hours of real-world usage, users have embraced PathPresenter’s best-in-class, lag-free imaging performance, super-easy sharing of images with colleagues (through URL links and/or QR codes), and the platform’s pathologist-built functionality.

The viral popularity of PathPresenter public has helped spur the adoption of PathPresenter’s robust and secure enterprise platform at tier-one institutions, becoming one of the fastest growing digital pathology enterprise workflow platforms for use in clinical care, education, and research. The “instant familiarity” of the PathPresenter platform and brand – used by pathologists at almost every major hospital in the world – translates into higher rates of adoption and user enthusiasm among pathologists and therefore a higher return on investment for institutions implementing new digital pathology enterprise workflows.

“Within 5 years, the majority of the world’s 1 billion glass slides produced each year will be digital. PathPresenter is building the roads and bridges to enable petabytes (soon to be exabytes) of digital pathology images to flow easily and securely within and between institutions to advance patient care, research, and pathology education,” said Patrick Myles, Chief Executive Officer of PathPresenter. “I would like to thank our community of 50,000+ PathPresenter users around the world for their unwavering support and their continued valuable input into the platform.”

“It is the feedback from great colleagues from around the world that has helped us build practical workflow solutions to use digital pathology in all three pillars of our work: clinical care of our patients by providing accurate diagnosis with prognostic information, educating new pathologists, and accelerating research for better care of patients,” added PathPresenter founder, Dr. Rajendra Singh. “We will continue to work tirelessly with colleagues, institutions, and other vendors to ensure we can truly revolutionize our field and make it the center of personalized medicine.”

About PathPresenter
PathPresenter is the global image sharing platform for pathology. We are on a mission to help democratize access to the world’s pathology knowledge by connecting pathologists to the vast expertise of their colleagues globally and providing a practical platform to access and use best-in-class AI models. Founded in 2017 by dermatopathologist and digital pathology innovator, Dr. Rajendra Singh, PathPresenter has been adopted by 30+ tier one medical institutions for clinical care, education, and research, and has built a thriving community of 50,000+ users in 172 countries to easily view and share digital pathology images and knowledge. Learn more about pathpresenter.com.

PathPresenter is available for primary diagnosis in the US during the COVID-19 public health emergency. In other countries, PathPresenter is intended for research and educational purposes only.

Contact Details
PathPresenter
Cory Batenchuk – SVP of Operations
+1 873-355-9913
cory@pathpresenter.com

Digital Pathology Efforts Ramp Up at Yale School of Medicine

Yale New Haven Health is among the leading healthcare systems deploying new digital pathology tools to optimize workflow and improve clinical and educational access to images. PathPresenter‘s educational workflow platform provides an easy on-ramp for managing and sharing the rapidly growing number of whole slide images across Yale New Haven Health.

Read the article here.